Ruby Wang
@rcjwang.bsky.social
ChinaHealthPulse.substack.com
🇬🇧🇨🇳 Doctor, health policy & medtech at LINTRIS Health & Royal Society of Medicine. Prev @ British Embassy Beijing, UNRCO China, British Medical Association, Schwarzman Scholars.
🇬🇧🇨🇳 Doctor, health policy & medtech at LINTRIS Health & Royal Society of Medicine. Prev @ British Embassy Beijing, UNRCO China, British Medical Association, Schwarzman Scholars.
Excited to share my latest post: I break down 5 ways #China is reshaping #globalhealth for the #globalsouth, but not as a #USAID replacement - remote-first #innovation, sovereign #data; public/private integration; community care, traditional blending. Link in comments #healthpolicy #development
April 22, 2025 at 11:31 AM
Excited to share my latest post: I break down 5 ways #China is reshaping #globalhealth for the #globalsouth, but not as a #USAID replacement - remote-first #innovation, sovereign #data; public/private integration; community care, traditional blending. Link in comments #healthpolicy #development
Thanks so much @robertpostings.bsky.social !
If you're interested in China or Health, please do follow my friend @rcjwang.bsky.social and check out her Substack China Health Pulse.
She writes great articles like this one, which breaks down some of the biggest myths about Chinese healthcare:
chinahealthpulse.substack.com/p/five-bigge...
She writes great articles like this one, which breaks down some of the biggest myths about Chinese healthcare:
chinahealthpulse.substack.com/p/five-bigge...
Five Biggest Myths I See About China’s Healthcare
Here’s what everyone keeps getting wrong - and why it really matters.
chinahealthpulse.substack.com
April 22, 2025 at 11:30 AM
Thanks so much @robertpostings.bsky.social !
On 9 April, Trump confirmed incoming Pharma tariffs. This shatters a decades long WTO precedent; that medicines are kept out of trade wars. The consequences: innovation slows. supply chains strain, foreign pharma loses & China hardens. My latest post on the #USChina #tariffs:
April 11, 2025 at 7:09 AM
Pt 2 of my special deep dive on #China’s #TwoSessions is out now—the only health-focused analysis of this key political event, incl “silver economy”#health #biotech #ageing #healthpolicy I also analyse context of Xi’s recent global CEO meeting — 25 % of the room was big Pharma!
March 31, 2025 at 1:07 PM
Pt 2 of my special deep dive on #China’s #TwoSessions is out now—the only health-focused analysis of this key political event, incl “silver economy”#health #biotech #ageing #healthpolicy I also analyse context of Xi’s recent global CEO meeting — 25 % of the room was big Pharma!
Reposted by Ruby Wang
China’s biotech is getting global attention. In my latest post at , I unpack 4 key truths behind the headlines. Link in comments:
#biotech #china #healthtech #healthpolicy #innovation
#biotech #china #healthtech #healthpolicy #innovation
March 26, 2025 at 12:14 PM
China’s biotech is getting global attention. In my latest post at , I unpack 4 key truths behind the headlines. Link in comments:
#biotech #china #healthtech #healthpolicy #innovation
#biotech #china #healthtech #healthpolicy #innovation
Was interviewed by on vaccine market access challenges for foreign pharma in China. These include domestic competition, vaccine hesitancy, regulatory hurdles, disease-specific stigma etc. #vaccines #pharma #china #health www.pharmaceutical-technology.com/features/big...
Big pharma faces headwinds in China as vaccine sales decline - Pharmaceutical Technology
Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.
www.pharmaceutical-technology.com
March 27, 2025 at 7:22 PM
Was interviewed by on vaccine market access challenges for foreign pharma in China. These include domestic competition, vaccine hesitancy, regulatory hurdles, disease-specific stigma etc. #vaccines #pharma #china #health www.pharmaceutical-technology.com/features/big...
China’s biotech is getting global attention. In my latest post at , I unpack 4 key truths behind the headlines. Link in comments:
#biotech #china #healthtech #healthpolicy #innovation
#biotech #china #healthtech #healthpolicy #innovation
March 26, 2025 at 12:14 PM
China’s biotech is getting global attention. In my latest post at , I unpack 4 key truths behind the headlines. Link in comments:
#biotech #china #healthtech #healthpolicy #innovation
#biotech #china #healthtech #healthpolicy #innovation
Most takes on China’s health are wrong. I debunk 5 of the biggest myths - from inequalities to innovation - because bad assumptions lead to real world consequences. Read my newsletter here: #China #health #healthpolicy #globalhealth #innovation #biotech open.substack.com/pub/chinahea...
Five Biggest Myths I See About China’s Healthcare
Here’s what everyone keeps getting wrong - and why it really matters.
open.substack.com
March 11, 2025 at 11:46 AM
Most takes on China’s health are wrong. I debunk 5 of the biggest myths - from inequalities to innovation - because bad assumptions lead to real world consequences. Read my newsletter here: #China #health #healthpolicy #globalhealth #innovation #biotech open.substack.com/pub/chinahea...
🚨I launched a newsletter!
“China Health Pulse” decodes how China is reshaping health policy, tech, life sciences markets and the future of global health.
Clear analysis, real insights—no noise. #China #Health #Biotech #HealthPolicy #Substack
Subscribe: open.substack.com/pub/chinahea...
“China Health Pulse” decodes how China is reshaping health policy, tech, life sciences markets and the future of global health.
Clear analysis, real insights—no noise. #China #Health #Biotech #HealthPolicy #Substack
Subscribe: open.substack.com/pub/chinahea...
March 4, 2025 at 2:16 PM
🚨I launched a newsletter!
“China Health Pulse” decodes how China is reshaping health policy, tech, life sciences markets and the future of global health.
Clear analysis, real insights—no noise. #China #Health #Biotech #HealthPolicy #Substack
Subscribe: open.substack.com/pub/chinahea...
“China Health Pulse” decodes how China is reshaping health policy, tech, life sciences markets and the future of global health.
Clear analysis, real insights—no noise. #China #Health #Biotech #HealthPolicy #Substack
Subscribe: open.substack.com/pub/chinahea...